Skip to content

Construction and clinical application of vaginal rehabilitation program for cervical cancer patients based on dilatation function

Construction and clinical application of vaginal rehabilitation program for cervical cancer patients based on dilatation function

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095713
Enrollment
Unknown
Registered
2025-01-10
Start date
2024-11-20
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Intervention group:To apply the early vaginal rehabilitation nursing program for cervical cancer patients with radiotherapy constructed in this study: Set up a multidisciplinary team with fixed member
Vaginal douching starts from the first day of radiotherapy, 2 to 4W after the end of radiotherapy or after the acute inflammatory period of radiotherapy (usually about 4w), starting to use vaginal dil
The expansion frequency is 2~3 times /w, continuous expansion of 5~10min/ times, at least continuous expansion for 1 year, if the patient is willing to use indefinitely. When the vaginal dilator is in
Control group:Rehabilitation protocol using traditional vaginal irrigation: Vaginal irrigation is from the first day of radiotherapy, and the frequency of irrigation is 1 to 2 times/day, and the flush

Sponsors

Sichuan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1 Patients with cervical cancer who did not undergo surgery with radiotherapy and chemotherapy (including external pelvic radiation and intracavitary radiotherapy); 2 The age range is 20 to 70 years; 3 Clear mind, no cognitive impairment, and cooperate with the treatment of patients; 4 Informed consent, voluntary participation in this study.

Exclusion criteria

Exclusion criteria: 1 With other malignant tumors; 2 Recurrence of cervical cancer and radiotherapy; 3 Patients who have received radiotherapy before; 4 cervical active bleeding; (5) Physical weakness caused by other physical diseases.

Design outcomes

Primary

MeasureTime frame
Vaginal stenosis;Vaginal infection;Adhesions vaginalis;

Secondary

MeasureTime frame
Vaginal cleanliness;The quality of sexual function;

Countries

China

Contacts

Public ContactTian Changying

Sichuan Cancer Hospital

1790823201@qq.com+86 189 0817 8873

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026